STAT3 and colorectal cancer: Kugimiya et al’s study17 on colorectal cancer verified Jab1 as a prognostic biomarker and the JAB1‐STAT3 over‐activation loop as playing a role in the recurrence of colorectal cancer following adjuvant chemotherapy.